Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Eduardo Davila

Concepts (221)

Concepts are derived automatically from a person's publications.

The timeline below shows the dates (blue tick marks) of publications associated with Eduardo Davila's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Eduardo Davila has written about over time.
Melanoma, Experimental, 5 publications between 2003 and 2016, average publication date November 2010. Cancer Vaccines, 2 publications between 2003 and 2019, average publication date June 2011. Toll-Like Receptor 2, 4 publications between 2008 and 2016, average publication date July 2011. Apoptosis, 6 publications between 2002 and 2020, average publication date June 2012. Antigens, Neoplasm, 5 publications between 2003 and 2024, average publication date January 2013. Myeloid Differentiation Factor 88, 7 publications between 2007 and 2021, average publication date April 2013. CD8-Positive T-Lymphocytes, 7 publications between 2002 and 2021, average publication date November 2013. Immunotherapy, Adoptive, 6 publications between 2008 and 2025, average publication date July 2015. T-Lymphocytes, 8 publications between 2002 and 2024, average publication date August 2015. Receptors, Antigen, T-Cell, 2 publications between 2010 and 2021, average publication date December 2015. Interleukin-1 Receptor-Associated Kinases, 3 publications between 2012 and 2020, average publication date February 2016. Melanoma, 7 publications between 2010 and 2024, average publication date December 2017. Protein Kinase Inhibitors, 4 publications between 2012 and 2024, average publication date September 2018. Neoplasms, 7 publications between 2012 and 2025, average publication date November 2019. Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, 2 publications between 2015 and 2025, average publication date February 2020. Chromones, 3 publications between 2017 and 2024, average publication date August 2020. Morpholines, 3 publications between 2017 and 2024, average publication date August 2020. Cell Engineering, 1 publications between 2021 and 2021, average publication date July 2021. Hematologic Neoplasms, 1 publications between 2023 and 2023, average publication date August 2023. DNA-Activated Protein Kinase, 1 publications between 2024 and 2024, average publication date October 2024.

To see the data from this visualization as text, click here.
Davila's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)